{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Primary membranoproliferative glomerulonephritis",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gemcitabine",
          "type": "Drug",
          "label": "Gemcitabine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_intravenous_immunoglobulin",
          "type": "Drug",
          "label": "Intravenous immunoglobulin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_primary_membranoproliferative_glomerulonephritis",
          "type": "Disease",
          "label": "Primary membranoproliferative glomerulonephritis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_b_cell_target",
          "type": "Target",
          "label": "B Cell Target",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_immunomodulation_pathway",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Sirolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Gemcitabine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Intravenous immunoglobulin",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_rituximab",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "针对B细胞的作用符合已知机制"
        },
        {
          "source": "t_b_cell_target",
          "target": "p_immunomodulation_pathway",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "B细胞通过免疫调节通路发挥作用"
        },
        {
          "source": "p_immunomodulation_pathway",
          "target": "d_primary_membranoproliferative_glomerulonephritis",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节影响肾小管增生症"
        },
        {
          "source": "drug_eculizumab",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Eculizumab针对补体系统，符合其作用机制"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "清除血浆中的有害因子，影响免疫功能"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有免疫抑制作用的细胞毒药物"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "抑制B细胞增殖的免疫抑制剂"
        },
        {
          "source": "drug_tacrolimus",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "靶向抑制T细胞，影响免疫反应"
        },
        {
          "source": "drug_prednisone",
          "target": "p_immunomodulation_pathway",
          "relation": "modulates",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "糖皮质激素通过减轻炎症作用"
        },
        {
          "source": "drug_azathioprine",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "影响细胞的增殖与免疫功能"
        },
        {
          "source": "drug_sirolimus",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "通过减少T/B细胞活性，调节免疫反应"
        },
        {
          "source": "drug_cyclosporine",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "抑制T细胞活化并减轻免疫反应"
        },
        {
          "source": "drug_gemcitabine",
          "target": "t_b_cell_target",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有潜在的免疫抑制效果，可减少细胞活性"
        },
        {
          "source": "drug_intravenous_immunoglobulin",
          "target": "p_immunomodulation_pathway",
          "relation": "modulates",
          "weight": 0.48,
          "agent": "Proponent",
          "rationale": "通过调节免疫反应支持治疗"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.74,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.8,
            "safety_risk": 0.3,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 2.3,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "存在 Drug→Target→Pathway→Disease 的完整路径"
            ],
            "safety_risk": [
              "未标注明显的安全性风险"
            ]
          },
          "confidence": "high",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H2",
          "score": 0.71,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.3,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.09
          },
          "graph_signals": {
            "support_weight": 2.2,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Eculizumab 针对补体系统对免疫调节有直接影响"
            ],
            "safety_risk": [
              "在此假设下，无明显安全性问题"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H3",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.65,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.75,
            "safety_risk": 0.4,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 1.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "清除有害因子的机制适合在MPGN中使用"
            ],
            "safety_risk": [
              "可能存在的不良反应目前未被具体标注"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H4",
          "score": 0.67,
          "components": {
            "mechanism_fit": 0.73,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.7,
            "safety_risk": 0.4,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.11
          },
          "graph_signals": {
            "support_weight": 1.6,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作为免疫抑制剂可用于MPGN相关免疫疾病"
            ],
            "safety_risk": [
              "安全性需要进一步评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H5",
          "score": 0.66,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.72,
            "safety_risk": 0.3,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.12
          },
          "graph_signals": {
            "support_weight": 1.5,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "可抑制B细胞增殖，有助于MPGN"
            ],
            "safety_risk": [
              "长期疗效及安全性不明确"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H6",
          "score": 0.63,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.67,
            "safety_risk": 0.4,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.14
          },
          "graph_signals": {
            "support_weight": 1.4,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "靶向抑制T细胞调整免疫反应"
            ],
            "safety_risk": [
              "潜在的不良反应需要关注"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H7",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.66,
            "class_prior": 0.55,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.65,
            "safety_risk": 0.3,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.13
          },
          "graph_signals": {
            "support_weight": 1.3,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "该药通过抑制炎症途径有潜在效果"
            ],
            "safety_risk": [
              "可能存在的糖皮质激素相关不良反应"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H8",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.6,
            "safety_risk": 0.3,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.14
          },
          "graph_signals": {
            "support_weight": 1.2,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "在免疫抑制领域已获得应用"
            ],
            "safety_risk": [
              "安全数据相对有限"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H9",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.55,
            "safety_risk": 0.3,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 1.1,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过影响免疫细胞的活性，有可能帮助MPGN"
            ],
            "safety_risk": [
              "需要注意的安全性没有明确定义"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H10",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.55,
            "safety_risk": 0.4,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 1.0,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "通过抑制免疫反应可能有应用前景"
            ],
            "safety_risk": [
              "临床应用中可能面临安全风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H11",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.45,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.16
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "有可能在免疫相关疾病中发挥作用"
            ],
            "safety_risk": [
              "安全性数据不足以支持使用"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        },
        {
          "hypothesis_id": "H12",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.48,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.45,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.18
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.0,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "可能通过调节免疫功能发挥作用"
            ],
            "safety_risk": [
              "目前有关安全性的信息有限"
            ]
          },
          "confidence": "medium",
          "uncertainties": []
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_rituximab",
            "via": [
              "t_b_cell_target",
              "p_immunomodulation_pathway"
            ],
            "to": "d_primary_membranoproliferative_glomerulonephritis",
            "success_criteria": "确认形成有效的作用机制通路",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "探讨 Rituximab 对 MPGN 治疗的临床证据",
          "讨论潜在的安全性问题和有效剂量"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_eculizumab",
            "via": [
              "t_b_cell_target",
              "p_immunomodulation_pathway"
            ],
            "to": "d_primary_membranoproliferative_glomerulonephritis",
            "success_criteria": "建立完整的作用机制链条",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Eculizumab 对补体系统影响的临床效果",
          "安全性和临床应对的可能冲突"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "现有假设的机制连接性相对良好，主要关注点在于补充机制细节与安全性问题，不需要再生种子。",
      "n": 4
    }
  }
}